Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia with interferon alpha
✍ Scribed by Egert, G. ;Kanz, L. ;Löhr, G. W. ;Fauser, A. A.
- Publisher
- Springer-Verlag
- Year
- 1990
- Weight
- 654 KB
- Volume
- 60
- Category
- Article
- ISSN
- 1432-0584
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Fourteen patients with Ph'-chromosome positive chronic myelogenous leukemia (CML) in first chronic phase were treated with recombinant interferon-alpha 2c. Interferon-alpha 2c 5 to 10 X 10(6) units s.c. was given for 12 weeks as an induction therapy. Maintenance treatment consisted of interferon-alp
## Abstract A newborn with congenital juvenile chronic myelogenous leukemia (JCML) is described. The diagnosis was suggested by the characteristic clinical and hematologic presentation, and was confirmed by the results of in‐vitro cultures of the hematopoietic progenitors, which showed excessive pr